Advocacy

Regarding Patient Safety and Quality Issues in End Stage Renal Disease Treatment Submitted by The American Association of Kidney Patients (AAKP) December 5, 2006 The American Association of Kidney Patients (AAKP) (www.aakp.org)

United States House of Representatives UnitedStatesSenate Re:Support for Lifetime Immunosuppressive Drug Coverage Saves Lives and Dollars Dear Members of the US House of Representatives and the US Senate:

Margaret A. Hamburg, M.D., Commissioner of Food and Drugs U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 Dear Dr. Hamburg: The Alliance for Home Dialysis (Alliance) is a coalition of kidney dialysis stakeholders representing patients, clinicians, providers, and industry.

Dr. Bernice Hecker Noridian Healthcare Solutions 6505 216th Street, SW Suite 200 Mountlake Terrace, WA 98043 Dear Dr. Hecker: The Alliance for Home Dialysis is a coalition of kidney dialysis stakeholdersrepresenting patients, clinicians, providers,and industry.

Ms. Marilyn Tavenner Administrator Centers for Medicare and Medicaid Services Department of Health and Human Services 200 Independence Avenue, SW Room 310G Washington, DC 20201 Dear Ms. Tavenner: The Alliance for Home Dialysis appreciates the opportunity to provide comments to the Centers for Medicare and Medicaid Services (CMS)